# A Pilot Study of Bevacizumab for Neoplastic Meningitis

> **NCT00924820** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 20 (actual)

## Conditions studied

- Neoplastic Meningitis

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00924820
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924820, "A Pilot Study of Bevacizumab for Neoplastic Meningitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00924820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*